Agenus (AGEN) Other Accumulated Expenses (2010 - 2026)

Agenus' (AGEN) quarterly Other Accumulated Expenses came in at $514000.0 in Q1 2026, down 89.76% year-on-year from $5.0 million in Q1 2025, and down 2.84% quarter-over-quarter from $529000.0 in Q4 2025.

Agenus (AGEN) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

Agenus' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $514000.0 for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 89.76% year-over-year to $514000.0 in Q1 2026; TTM through Mar 2026 was $514000.0, a 89.76% decrease from a year earlier, with the FY2025 full-year figure at $529000.0, down 93.23% from the prior year.
  • Other Accumulated Expenses fell to $514000.0 in Q1 2026 per AGEN's latest filing, from $529000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $14.0 million in Q1 2024 and bottomed at $514000.0 in Q1 2026.
  • The 5-year median for Other Accumulated Expenses is $7.3 million (2024), against an average of $7.7 million.
  • Across the five-year window, Other Accumulated Expenses soared 260.16% in 2023 and slumped 93.23% in 2025, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $11.5 million in 2022, then climbed by 21.45% to $13.9 million in 2023, then tumbled by 43.82% to $7.8 million in 2024, then slumped by 93.23% to $529000.0 in 2025, then retreated by 2.84% to $514000.0 in 2026.
  • Per Business Quant, the three latest AGEN Other Accumulated Expenses figures stand at $514000.0 (Q1 2026), $529000.0 (Q4 2025), and $7.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.68 Bn 467.89 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.24 Bn 114.99 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.08 Bn 61.33 Bn 3.31 Bn
7 Belite Bio 62.46 Bn 62.46 Bn -
8 Argenx Se 55.93 Bn 50.75 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.59 Bn 34.58 Bn 959.66 Mn
10 Agenus 230.49 Mn 195.50 Mn 33.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 514,000.00
Dec 31, 2025 529,000.00
Sep 30, 2025 7.36 Mn
Jun 30, 2025 3.89 Mn
Mar 31, 2025 5.02 Mn
Dec 31, 2024 7.82 Mn
Sep 30, 2024 7.29 Mn
Jun 30, 2024 7.07 Mn
Mar 31, 2024 14.03 Mn
Dec 31, 2023 13.92 Mn
Sep 30, 2023 13.42 Mn
Jun 30, 2023 13.27 Mn
Mar 31, 2023 12.94 Mn
Dec 31, 2022 11.46 Mn
Sep 30, 2022 3.73 Mn
Jun 30, 2022 3.81 Mn
Mar 31, 2022 4.61 Mn
Dec 31, 2021 6.55 Mn
Sep 30, 2021 6.78 Mn
Jun 30, 2021 5.36 Mn